Depósito Digital de Documentos de la UAB Encontrados 2 registros  La búsqueda tardó 0.00 segundos. 
1.
11 p, 652.6 KB Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type : a cross-sectional patient survey* / Mahil, Satveer K. ; Yates, Mark (King's College London) ; Langan, Sinead M. (London School of Hygiene and Tropical Medicine) ; Yiu, Zenas Z.N. ; Tsakok, Teresa ; Dand, Nick ; Mason, Kayleigh J. ; McAteer, Helen ; Meynell, Freya ; Coker, Bolaji ; Vincent, A. (Guy's and St Thomas' NHS Foundation Trust) ; Urmston, Dominic ; Vesty, Amber ; Kelly, J. (The University of Manchester) ; Lancelot, Camille (France Veterinary International) ; Moorhead, Lucy (Guy's and St Thomas' NHS Foundation Trust) ; Bachelez, Hervé (Université Paris Cité) ; Bruce, I.N. (The University of Manchester) ; Capon, Francesca (King's College London) ; Contreras, Claudia Romina (Universidad Nacional de Asunción) ; Cope, Andrew P. (Kingston College United Kingdom) ; De La Cruz, C. (University of Santiago, Chile) ; Di Meglio, Paola (Newcastle University) ; Gisondi, Paolo (University of Verona) ; Hyrich, Kimme (The University of Manchester) ; Jullien, Denis (Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon)) ; Lambert, Julien ; Marzo-Ortega, H. (Leeds Teaching Hospitals NHS Trust) ; McInnes, Iain B. (University of Glasgow) ; Naldi, L. (San Bortolo Hospital) ; Norton, Sam (King's College London) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Sengupta, Raj (Royal National Hospital For Rheumatic Diseases NHS Foundation Trust) ; Spuls, Phyllis (University of Amsterdam) ; Torres, Tiago (Centro Hospitalar e Universitário do Porto) ; Warren, Richard B. (The University of Manchester) ; Waweru, Hoseah (Upper Hill Medical Centre) ; Weinman, John (King's College London) ; Griffiths, Chris E.M. (The University of Manchester) ; Barker, Jonathan (The Kings College) ; Brown, Matthew A. (Guy's and St Thomas' NHS Foundation Trust) ; Galloway, James B. ; Smith, Catherine (King's College London)
Background: Registry data suggest that people with immune-mediated inflammatory diseases (IMIDs) receiving targeted systemic therapies have fewer adverse coronavirus disease 2019 (COVID-19) outcomes compared with patients receiving no systemic treatments. [...]
2021 - 10.1111/bjd.19755
British journal of dermatology, Vol. 185 Núm. 1 (july 2021) , p. 80-90  
2.
11 p, 255.5 KB Maintenance of clinical efficacy and radiographic benefit through two years of ustekinumab therapy in patients with active psoriatic arthritis : results from a randomized, placebo-controlled phase III trial / Kavanaugh, Arthur (University of California) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Gottlieb, Alice B. (Tufts Medical Center) ; Ritchlin, Christopher (University of Rochester) ; Li, Shu (Janssen Pharmaceutica) ; Wang, Yuhua (Janssen Pharmaceutica) ; Mendelsohn, Alan M. (Janssen Pharmaceutica) ; Song, Michael (Janssen Pharmaceutica) ; Zhu, Yaowei (Janssen Pharmaceutica) ; Rahman, Proton (Memorial University of Newfoundland) ; McInnes, Iain B. (University of Glasgow) ; Universitat Autònoma de Barcelona
To evaluate the efficacy and safety of ustekinumab through 2 years in adult patients with active psoriatic arthritis (PsA). A total of 615 adult patients with active PsA were randomized to placebo, ustekinumab 45 mg, or ustekinumab 90 mg, at weeks 0, 4, and every 12 weeks through week 88 (last dose). [...]
2015 - 10.1002/acr.22645
Arthritis Care & Research, Vol. 67, issue 12 (Dec. 2015) , p. 1739-1749  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.